Compile Data Set for Download or QSAR
Report error Found 166 Enz. Inhib. hit(s) with all data for entry = 10137
TargetSynaptic vesicular amine transporter(Rat)
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  1.90nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Rat)
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  1.90nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Rat)
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  1.90nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  2.60nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  2.60nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Rat)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516376(US11053242, Compound 1-1)
Affinity DataKi:  2.60nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  2.60nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516376(US11053242, Compound 1-1)
Affinity DataKi:  5.20nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516505(US11053242, Compound 5-50)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516379(US11053242, Compound 2-1)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516380(US11053242, Compound 2-2)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516381(US11053242, Compound 2-3)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516382(US11053242, Compound 2-4)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516511(US11053242, Compound 6-1)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516383(US11053242, Compound 2-5)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516512(US11053242, Compound 6-2)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516384(US11053242, Compound 2-6)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516513(US11053242, Compound 6-4)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516385(US11053242, Compound 2-7)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516514(US11053242, Compound 6-5)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516386(US11053242, Compound 2-8)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516515(US11053242, Compound 6-6)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516387(US11053242, Compound 2-9)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516516(US11053242, Compound 6-7)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516388(US11053242, Compound 2-10)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516389(US11053242, Compound 2-11)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516518(US11053242, Compound 6-9)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516390(US11053242, Compound 2-12)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516519(US11053242, Compound 6-10)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516391(US11053242, Compound 2-13)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516520(US11053242, Compound 6-11)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516392(US11053242, Compound 2-14)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516489(US11053242, Compound 5-31)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516490(US11053242, Compound 5-32)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516493(US11053242, Compound 5-37)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516499(US11053242, Compound 5-44)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516503(US11053242, Compound 5-48)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516409(US11053242, Compound 2-32)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516411(US11053242, Compound 2-34)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516413(US11053242, Compound 2-36)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516416(US11053242, Compound 2-39)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516418(US11053242, Compound 3-2)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516521(US11053242, Compound 6-13)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516393(US11053242, Compound 2-15)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516522(US11053242, Compound 6-14)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516394(US11053242, Compound 2-16)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516396(US11053242, Compound 2-18)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516525(US11053242, Compound 9-1 | US11053242, Compound 9-...)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516397(US11053242, Compound 2-19)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM516398(US11053242, Compound 2-21)
Affinity DataKi: <10nMAssay Description:The human Ki's for the compounds listed in Table 11 were determined using a slightly modified procedure shown below (see data in column under the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

Displayed 1 to 50 (of 166 total ) | Next | Last >>
Jump to: